These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 5785018)

  • 1. Detection of the heterozygote of Wilson's disease.
    O'Reilly S; Weber P; Pollycove M; Shipley L
    J Nucl Med; 1969 Mar; 10(3):143-4. PubMed ID: 5785018
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radioactive copper in the diagnosis of Wilson's disease].
    Czlonkowska A; Wehr H; Galewicz A; Harmak E; Rodo M; Wald I
    Pol Tyg Lek; 1973 May; 28(17):597-9. PubMed ID: 4712325
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kinetics of radioactive copper in Wilson's disease].
    Willvonseder R; Goldstein NP; Tauxe WN
    Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
    [No Abstract]   [Full Text] [Related]  

  • 5. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proceedings: Differentiation of homozygote and heterozygote, therapy and follow-up study in 4 families with Wilson's disease].
    Abendschein Th; Przuntek H; Wesch H; Gäng V
    MMW Munch Med Wochenschr; 1975 May; 117(20):842. PubMed ID: 805973
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I
    Prog Liver Dis; 1972; 4():511-25. PubMed ID: 4569009
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
    Willvonseder R; Goldstein NP; Tauxe WN
    Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
    [No Abstract]   [Full Text] [Related]  

  • 10. The liver-thigh 64Cu ratio in Wilson's disease.
    Levi AJ; Williams HS
    Clin Sci; 1968 Apr; 34(2):379-83. PubMed ID: 5690128
    [No Abstract]   [Full Text] [Related]  

  • 11. [Occurrence of copper metabolism abnormalities in the families of four individuals with newly diagnosed Wilson's disease].
    Dastych M
    Vnitr Lek; 1997 Feb; 43(2):87-90. PubMed ID: 9245074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heterozygote test using 64 Cu in Wilson's disease].
    Günther K; Biesold D; Lössner J; Löbe J
    Radiol Diagn (Berl); 1975; 16(1):61-8. PubMed ID: 1197691
    [No Abstract]   [Full Text] [Related]  

  • 13. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's Disease and various control groups.
    Walshe JM; Potter G
    Q J Med; 1977 Oct; 46(184):445-62. PubMed ID: 413153
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of liver enzymes, serum ceruloplasmin and urine copper in parents of children with Wilson's disease.
    Haghighat M; Dehghani SM; Imanieh MH; Gholami S
    Saudi Med J; 2008 Jul; 29(7):1056-7. PubMed ID: 18626543
    [No Abstract]   [Full Text] [Related]  

  • 15. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper.
    O'Reilly S; Weber PM; Oswald M; Shipley L
    Arch Neurol; 1971 Jul; 25(1):28-32. PubMed ID: 5146408
    [No Abstract]   [Full Text] [Related]  

  • 17. [Wilson's disease in Switzerland. Clinical, genetic and biochemical studies].
    Tschumi A; Colombo JP; Moser H
    Schweiz Med Wochenschr; 1973 Jan; 103(3):89-95. PubMed ID: 4683518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostic and therapeutic experiences in Wilson's disease. I. Pathogenesis, biochemistry and clinical aspects of Wilson's disease].
    Eichner B; Biesold D; Günther K; Lössner J; Bachmann H; Diessner H
    Folia Clin Int (Barc); 1974 Oct; 24(10):696-707. PubMed ID: 4430389
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies with radioactive copper (64Cu and 67Cu): abdominal scintiscans in patients with Wilson's disease.
    Osborn SB; Szaz KF; Walshe JM
    Q J Med; 1969 Oct; 38(152):467-74. PubMed ID: 5355538
    [No Abstract]   [Full Text] [Related]  

  • 20. [Wilson's disease. I].
    Sánchez Rodríquez A; González Macias J; Diez Jarilla JL; Suquia Múgica B; de Portugal Alvarez J
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):68-73. PubMed ID: 6753060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.